Search

Search Results

• Sarcoidosis and multiple sclerosis: systemic toxicity associated with the use of interferon-beta therapy

  C. Carbonelli, S. Montepietra, A. Caruso, A. Cavazza, C. Feo, F. Menzella, L. Motti, L. Zucchi

  2015-12-03

  https://doi.org/10.4081/monaldi.2012.165

  2101

  PDF: 870
• 

  Erasmus syndrome: The association of systemic sclerosis and silicosis

  Miguel Osejo-Betancourt, Pedro Chaparro-Mutiz

  2022-04-12

  https://doi.org/10.4081/monaldi.2022.2223

  1661

  PDF: 494
• 

  The brain-heart connection: a multiple sclerosis relapse presenting as Takotsubo Syndrome. A case report and literature review

  Andrea Dell'Aquila, Edoardo Sciatti, Enrico Vizzardi, Marco Metra

  2020-04-02

  https://doi.org/10.4081/monaldi.2020.1153

  1739

  PDF: 1139
• 

  A case of lung injury resembling diffuse pulmonary hemorrhage after the first administration of alemtuzumab in a patient with multiple sclerosis. Role of the HRCT

  Gaia Cipolla, Rosalba Relo, Elisa Pasciuta, Domenica Catalano, Federica Lo Bello, Irene Coppolino, Paolo Ruggeri, Alfio Proietto, Maria Buccafusca, Paola Maria Cutroneo, Gianluca Trifirò, Gaetano Caramori

  2020-07-24

  https://doi.org/10.4081/monaldi.2020.1352

  953

  PDF: 497

• Assessing disease activity in scleroderma-related interstitial lung disease: a review and practical guide to management

  Tochukwu Adizie, Lauren Dolan, Aqusa Zahid, Ahmed Fahim

  2024-09-25

  https://doi.org/10.4081/monaldi.2024.2957

  977

  PDF_EARLY VIEW: 453

• Downhill: a new rehabilitation frontier. A systematic review of the literature

  Matteo Tamburlani, Rossana Cuscito, Alessio D’Angelo, Giovanni Galeoto, Leonardo Papi, Ilaria Ruotolo, Francesca Santini, Annamaria Servadio, Edoardo Tirelli, Giovanni Sellitto

  2025-01-16

  https://doi.org/10.4081/monaldi.2025.3071

  737

  PDF: 396

  SUPPLEMENTARY MATERIAL: 26